Every New York stock exchange trading day I’m posting a daily dividend stock or fund review. I’ll share the three chief qualities of just one equity or fund that could be selected for a dividend stock portfolio I’ve named the Safari to Sweet Success.

This week the portfolio I’m building (my Safari To Sweet Success portfolio) seeks a high-yield and growing stock in the healthcare sector. 

That healthcare sector includes ten industries all related to testing, diagnosing and treating what ails us. Healthcare industries are: biotechnology; diagnostics & research; drug manufacturers – major and – specialty & generic; healthcare plans; long-term care facilities; medical care; devices; distribution; supplies.

Today I’m reviewing a large-cap US drug manufacturer – major. Its name is Pfizer Inc. Its trading ticker symbol is PFE.  

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many consumer healthcare products. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH).

The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas.

The EH segment offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives.

This segment also engages in the research and development, as well as contract manufacturing activities.

Pfizer Inc. has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.;Merck KGaA; and Neofluidics, LLC. 

It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. 

Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.